CVE:RLV

Relevium Technologies Stock Forecast, Price & News

C$0.02
0.00 (0.00 %)
(As of 08/4/2021 12:33 PM ET)
Add
Compare
Today's Range
C$0.02
C$0.02
50-Day Range
C$0.02
C$0.03
52-Week Range
C$0.02
C$0.09
Volume117,250 shs
Average Volume765,405 shs
Market CapitalizationC$4.22 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive RLV News and Ratings via Email

Sign-up to receive the latest news and ratings for Relevium Technologies and its competitors with MarketBeat's FREE daily newsletter.


About Relevium Technologies

Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand name; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Relevium Technologies (CVE:RLV) Frequently Asked Questions

What stocks does MarketBeat like better than Relevium Technologies?

Wall Street analysts have given Relevium Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Relevium Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Relevium Technologies' stock been impacted by COVID-19 (Coronavirus)?

Relevium Technologies' stock was trading at C$0.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RLV shares have increased by 33.3% and is now trading at C$0.02.
View which stocks have been most impacted by COVID-19
.

Who are Relevium Technologies' key executives?

Relevium Technologies' management team includes the following people:
  • Mr. Aurelio Useche C.M.A., M.B.A., Pres, CEO & Director (Age 53, Pay $205.74k)
  • Mr. Mark Anthony Billings C.F.A., M.B.A., CFA, MBA, Chief Financial Officer (Age 51)
  • Mr. Edward Ierfino, Mang. of Investor Relations (Age 53)
  • Mr. Abis Hussain, Sr. Marketing Officer
  • Mr. David A. Johnson, Corp. Sec.

Who are some of Relevium Technologies' key competitors?

What other stocks do shareholders of Relevium Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Relevium Technologies investors own include Arctic Star Exploration (ADD), Eldorado Gold (ELD), Freedom Leaf (FRLF), Macquarie Infrastructure (MIC), Spero Therapeutics (SPRO), SoFi Weekly Income ETF (TGIF), Acquired Sales (AQSP), Aphria (APHA), (APHA) and Aldeyra Therapeutics (ALDX).

What is Relevium Technologies' stock symbol?

Relevium Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RLV."

How do I buy shares of Relevium Technologies?

Shares of RLV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Relevium Technologies' stock price today?

One share of RLV stock can currently be purchased for approximately C$0.02.

How much money does Relevium Technologies make?

Relevium Technologies has a market capitalization of C$4.22 million and generates C$1.00 million in revenue each year.

What is Relevium Technologies' official website?

The official website for Relevium Technologies is www.releviumcorp.com.

Where are Relevium Technologies' headquarters?

Relevium Technologies is headquartered at 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada.

How can I contact Relevium Technologies?

Relevium Technologies' mailing address is 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada. The company can be reached via phone at +1-514-8248559.


This page was last updated on 8/5/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.